Search Result "ErectileDysfunction drugs"
Drugs from Animal Venoms: Overcoming the Challenges to Treat ErectileDysfunction
Journal: Venoms and Toxins
Volume: 2 Issue: 2 Year: 2022 Page: 2-3
Author(s): Maria Elena de Lima,Kênia Pedrosa Nunes
Contemporary Trends in Drug Repurposing: Identifying New Targets for Existing Drugs
Ebook: Frontiers In Medicinal Chemistry
Volume: 10 Year: 2023
Author(s):
Doi: 10.2174/9789815165043123100005
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report
Journal: Current Drug Safety
Volume: 15 Issue: 1 Year: 2020 Page: 69-72
Author(s): Stefano Dastoli,Luigi Francesco Iannone,Luigi Bennardo,Martina Silvestri,Caterina Palleria,Steven Paul Nisticò,Giovambattista De Sarro,Emilio Russo
Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension
Journal: Current Drug Metabolism
Volume: 14 Issue: 2 Year: 2013 Page: 265-269
Author(s): Serap Gur,Philip J. Kadowitz,Ahmet Gokce,Suresh C. Sikka,Utku Lokman,Wayne J.G. Hellstrom
A Rare Case of Drug-induced Erectile Dysfunction with Adalimumab andCertolizumab Solved after Switch to Ustekinumab in a Crohn's DiseasePatient
Journal: Current Drug Safety
Volume: 18 Issue: 3 Year: 2023 Page: 374-378
Author(s): Jaime Torelló Iserte,Jose Manuel Herrera-Justiniano
Drug Repurposing against Novel Therapeutic Targets in Plasmodium falciparum for Malaria: The Computational Perspective
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 38 Year: 2024 Page: 6272-6287
Author(s):
Repurposing of the PDE5 Inhibitor Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Neonates
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 12 Year: 2021 Page: 2418-2437
Author(s): Erika L. Poitras,Stephen L. Gust,Paul M. Kerr,Frances Plane
Is Erectile Dysfunction an Example of Abnormal Endothelial Function?
Journal: Current Vascular Pharmacology
Volume: 14 Issue: 2 Year: 2016 Page: 163-167
Author(s): Christopher Blick,Robert W. Ritchie,Mark E. Sullivan
Lipoprotein (a) and Cardiovascular Risk: The Show Must go on
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 10 Year: 2017 Page: 989-1006
Author(s): Niki Katsiki,Khalid Al-Rasadi,Dimitri P. Mikhailidis
Adulteration of Synthetic Substances in Dietary Supplements
Ebook: Frontiers in Drug Safety
Volume: 1 Year: 2018
Author(s): Nicholas Schramek,Uwe Wollein
Doi: 10.2174/9781681086750118010010